DARE BIOSCIENCE INC's ticker is DARE and the CUSIP is 23666P101. A total of 21 filers reported holding DARE BIOSCIENCE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,722 | -31.4% | 20,000 | 0.0% | 0.00% | – |
| Q1 2024 | $9,804 | +1486.4% | 20,000 | +900.0% | 0.00% | – |
| Q4 2023 | $618 | -78.4% | 2,000 | -67.7% | 0.00% | – |
| Q3 2023 | $2,861 | -49.3% | 6,200 | 0.0% | 0.00% | – |
| Q2 2023 | $5,642 | -12.5% | 6,200 | 0.0% | 0.00% | – |
| Q1 2023 | $6,448 | -46.3% | 6,200 | -56.3% | 0.00% | – |
| Q4 2022 | $12,000 | -52.0% | 14,200 | -43.7% | 0.00% | – |
| Q3 2022 | $25,000 | -7.4% | 25,200 | +13.5% | 0.00% | – |
| Q2 2022 | $27,000 | -12.9% | 22,200 | +6.9% | 0.00% | – |
| Q1 2022 | $31,000 | -8.8% | 20,763 | +23.9% | 0.00% | – |
| Q4 2021 | $34,000 | +88.9% | 16,763 | +55.7% | 0.00% | – |
| Q3 2021 | $18,000 | +80.0% | 10,763 | +86.8% | 0.00% | – |
| Q2 2021 | $10,000 | +900.0% | 5,763 | +655.3% | 0.00% | – |
| Q1 2021 | $1,000 | -87.5% | 763 | -87.3% | 0.00% | – |
| Q4 2020 | $8,000 | +33.3% | 6,000 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +20.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 326,243 | $706,000 | 0.62% |
| Rock Springs Capital Management LP | 62,500 | $135,000 | 0.01% |
| Artemis Wealth Advisors, LLC | 1,762 | $1,905 | 0.00% |
| Inspire Investing, LLC | 403 | $1,000 | 0.00% |
| UBS Group AG | 4,244 | $9,000 | 0.00% |
| WASHINGTON TRUST BANK | 23 | $0 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 5,848 | $13,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,467 | $25,000 | 0.00% |
| BlackRock Inc. | 643 | $1,000 | 0.00% |
| Citadel Advisors | 11,280 | $24,000 | 0.00% |